select trial semaglutide nejm Phase 3 of in Metabolic Dysfunction–Associated Steatohepatitis What the SELECT trial of
Description
However, they contain the same active ingredient as the brand-name drugs Ozempic and Wegovy

Tirzepatide is a GIPR and GLP-1R agonist with a half-life of 117 hours that slows gastric emptying and decreases food intake

Your healthcare provider may make adjustments, to the dosage depending on your needs and medical condition

Their expertise and guidance are crucial in educating patients about the potential side effects of semaglutide, including dizziness, and in developing personalized management plans
